- Home
- TFSL vs CNTA Comparison
TFSL vs CNTA Comparison
Compare TFSL & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TFSL | CNTA |
|---|---|---|
| Founded | 1938 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.5B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TFSL | CNTA |
|---|---|---|
| Price | $13.62 | $26.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $40.89 |
| AVG Volume (30 Days) | 733.7K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 8.44% | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.16 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $167.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.29 | $9.60 |
| 52 Week High | $15.42 | $30.58 |
Technical Indicators
Market Signals| Indicator | TFSL | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 47.65 |
| Support Level | $13.15 | $24.62 |
| Resistance Level | $13.90 | $26.31 |
| Average True Range (ATR) | 0.28 | 1.42 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 31.69 | 28.55 |
Price Performance
Historical ComparisonAbout TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.